业界动态国内医卫资讯

阿柏西普 8 mg 为糖尿病性水肿带来真实世界获益

Medscape News · 2026-10-29 14:12

摘要

在真实世界临床实践中,接受高剂量阿柏西普治疗的初治糖尿病性水肿患者视力更好、视网膜肿胀更轻,尤其是基线视力较差的患者。Medscape Medical News

English
Aflibercept 8 mg Delivers Real-World Gains in Diabetic Edema

In real-world practice, treatment-naive patients with diabetic edema who receive high-dose aflibercept have better vision and less retinal swelling, especially those with worse baseline vision. Medscape Medical News

内容仅供参考,不构成诊疗建议,不能替代执业医师的诊断。

← 返回元界